secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2021-12-27T23:59:59+00:00
Accession:  0001104659-21-153622
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros Pharmaceuticals raises $7.5M in registered direct offering and private placement
--------------------------------------------------------------------------------

- Sold 2,186,589 shares at $3.43 each to accredited investors, including largest shareholder.
- Issued warrants to purchase up to 1,639,942 shares at $3.50, exercisable for five years.
- Net proceeds expected ~$6.9M after fees; used for men's health platform expansion and working capital.
- Katalyst Securities served as financial advisor; receives $560K fee and 110,000 warrants.
- Closing occurred December 27, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465921153622/0001104659-21-153622-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465921153622/tm2136334d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-153622

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer